Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

112
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
112
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

371
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
371
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tenacibaculum xiamenense sp. nov., an algicidal bacterium isolated from coastal seawater.

International journal of systematic and evolutionary microbiology·2013
Same author

The anchoring protein SAP97 influences the trafficking and localisation of multiple membrane channels.

Biochimica et biophysica acta·2013
Same author

Aegilops tauschii draft genome sequence reveals a gene repertoire for wheat adaptation.

Nature·2013
Same author

Draft genome of the wheat A-genome progenitor Triticum urartu.

Nature·2013
Same author

Citreoviridin enhances tumor necrosis factor-α-induced adhesion of human umbilical vein endothelial cells.

Toxicology and industrial health·2013
Same author

Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE).

Clinical rheumatology·2013

Related Experiment Video

Updated: Jul 18, 2025

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

10.1K

FcγRIIB expression increases during primary biliary cholangitis.

Xiuzhu Gao1, Heming Ma1, Junqi Niu1

  • 1Department of Hepatology, First Hospital of Jilin University, Jilin University, 71 Xinmin Street, Changchun, Jilin Province 130021, China.

Molecular Immunology
|August 27, 2023
PubMed
Summary

Fc receptor IIB (FcγRIIB) expression is elevated in primary biliary cholangitis (PBC) patients. This finding in B cells and liver tissue offers new insights into PBC pathogenesis and potential therapeutic targets.

Keywords:
AntibodyB cellFcγRIgG

More Related Videos

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Related Experiment Videos

Last Updated: Jul 18, 2025

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

10.1K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Area of Science:

  • Immunology
  • Hepatology
  • Autoimmune Diseases

Background:

  • Primary biliary cholangitis (PBC) is a severe autoimmune liver disease with unknown causes and limited treatment options.
  • B-cell antibodies and Fc gamma receptors (FcγRs) are crucial in immune regulation and autoimmune disease prevention.
  • Understanding the role of FcγRs in PBC is essential for developing effective therapies.

Purpose of the Study:

  • To investigate the expression of FcγRIIB on B cells and in liver tissue of patients with primary biliary cholangitis (PBC).
  • To evaluate the correlation between FcγRIIB expression and disease status in PBC.
  • To explore the potential of FcγRIIB as a therapeutic target for PBC.

Main Methods:

  • Flow cytometry (FACS) was used to quantify B cells and FcγRIIB expression on peripheral blood mononuclear cells.
  • Enzyme-linked immunosorbent assay (ELISA) measured soluble FcγR levels in plasma.
  • Immunohistochemistry (IHC) visualized intrahepatic FcγRIIB and CD19 expression.

Main Results:

  • FcγRIIB expression on B cells was significantly higher in PBC patients compared to healthy controls (P < 0.0001).
  • Plasma levels of soluble FcγRIIB were elevated in PBC patients (P = 0.0009) and decreased with ursodeoxycholic acid treatment (P = 0.0236).
  • Increased intrahepatic CD19 and FcγRIIB expression was observed in PBC patients' liver tissue.

Conclusions:

  • Elevated FcγRIIB expression on B cells and in the liver is a key feature of primary biliary cholangitis (PBC).
  • FcγRIIB may play a significant role in PBC pathogenesis.
  • Targeting FcγRIIB presents a potential new therapeutic strategy for PBC management.